InNexus Biotechnology Inc. (IXS)
Interview with: Dr. Charles A. Morgan, President and Director
Business News, Financial News, Stocks, Money & Investment Ideas, CEO Interview
and Information on their next generation of therapeutic,
monoclonal antibodies using a SuperAntibody Technology Platform. |
Cover Story
CEOCFO
Interview Index
CEOCFO Current
Issue
Future Features
Analyst Interviews
Corporate
Financials
Archived Interviews
About CEOCFOinterviews.com
Contact
& Ordering |
This is a printer friendly page!
InNexus
Biotechnology’s SuperAntibodies
is the only alternative for biotechs and pharmaceuticals not wanting to use toxic agents
to increase the potency of their antibodies
Healthcare
Biotechnology
(IXS-Toronto: Venture)
InNexus Biotechnology Inc.
Dr. Charles A. Morgan
President and Director
Interview conducted by:
Lynn Fosse
Senior Editor
CEOCFOinterviews.com
January 2004
Left click below to view
this Newsletter story and:
Request
an Investor Kit
Instant Access:
To find out more about:
InNexus
Biotechnology Inc. (IXS)
you may order the complete text of our
interview. To view a copy of this highly informative interview, left click here: ViewIXS
disclaimer
|
